Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors

por Al-Efraij, Khalid, Aljama, Mohammed A, Kennecke, Hagen Fritz
Publicado 2015

Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises

por Alkharabsheh, Omar, Trisel, Zachary, Badami, Sunil, Aljama, Mohammed A., Sidiqi, M. Hasib
Publicado 2021

Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia

por Issa, Hussain, Al-Momen, Sami, Bseiso, Bahaa, Al-Janobi, Ghada Ali, Aljama, Mohammed A, Almousa, Fadel Ali, Al-Jarodi, Mahdi E, Al-Salem, Ahmed H
Publicado 2011

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation

por Sidiqi, M. Hasib, Aljama, Mohammed A., Jevremovic, Dragan, Morice, William G., Timm, Michael, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Gonsalves, Wilson I., Kumar, Shaji, Kapoor, Prashant, Kourelis, Taxiarchis, Leung, Nelson, Hogan, William J., Gertz, Morie
Publicado 2018

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

por Sidiqi, M. Hasib, Aljama, Mohammed A., Bin Riaz, Irbaz, Dispenzieri, Angela, Muchtar, Eli, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dingli, David, Leung, Nelson, Gonsalves, Wilson I., Kapoor, Prashant, Kourelis, Taxiarchis V., Hogan, William J., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A.
Publicado 2018

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

por Sidiqi, M. Hasib, Al Saleh, Abdullah S., Leung, Nelson, Jevremovic, Dragan, Aljama, Mohammed A., Gonsalves, Wilson I., Buadi, Francis K., Kourelis, Taxiarchis V., Warsame, Rahma, Muchtar, Eli, Hobbs, Miriam A., Lacy, Martha Q., Dingli, David, Go, Ronald S., Hayman, Suzanne R., Rajkumar, S. Vincent, Dispenzieri, Angela, Gertz, Morie A., Kumar, Shaji K., Fonseca, Rafael, Kapoor, Prashant
Publicado 2020

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

por Sidiqi, M. Hasib, Aljama, Mohammed, Kumar, Shaji K., Jevremovic, Dragan, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dingli, David, Gonsalves, Wilson I., Fonder, Amie L., Hobbs, Miriam A., Hwa, Yi Lisa, Kapoor, Prashant, Kourelis, Taxiarchis, Leung, Nelson, Muchtar, Eli, Lust, John A., Kyle, Robert A., Go, Ronald S., Rajkumar, Vincent S., Gertz, Morie A., Dispenzieri, Angela
Publicado 2020